Trill AB's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Dec 8, 2025
- Accession no.
- 0001104659-25-119360
- Filed
- Dec 8, 2025, 5:15 PM ET
- Trade date
- Nov 17-25, 2025
- Filing delay
- 21 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.63M. It was filed 21 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trill ABCIK 0001887436 | 10% Owner |
| Stahlberg JanCIK 0001983161 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Shares | PPurchaseAcquired | +187,393 | $6.52 | +$1,221,165.22 | 7,951,858 | Indirect | |
| Nov 18, 2025 | Common Shares | PPurchaseAcquired | +182,882 | $6.75 | +$1,234,618.09 | 8,134,740 | Indirect | |
| Nov 19, 2025 | Common Shares | PPurchaseAcquired | +240,352 | $7.21 | +$1,732,361.08 | 8,375,092 | Indirect | |
| Nov 20, 2025 | Common Shares | PPurchaseAcquired | +128,426 | $7.41 | +$951,212.85 | 8,503,518 | Indirect | |
| Nov 21, 2025 | Common Shares | PPurchaseAcquired | +208,872 | $7.41 | +$1,547,574.42 | 8,712,390 | Indirect | |
| Nov 24, 2025 | Common Shares | PPurchaseAcquired | +40,253 | $7.89 | +$317,720.95 | 8,752,643 | Indirect | |
| Nov 25, 2025 | Common Shares | PPurchaseAcquired | +73,099 | $8.57 | +$626,816.62 | 8,825,742 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.